Search

  • Auftragsstatus
  • Eilbestellung
  • Aktionen
ElementsucheElementsucheStruktursucheStruktursuche
2-Methylimidazo-[4,5-c]-pyridin, 99 %, Thermo Scientific Chemicals
2-Methylimidazo-[4,5-c]-pyridin, 99 %, Thermo Scientific Chemicals
2-Methylimidazo-[4,5-c]-pyridin, 99 %, Thermo Scientific Chemicals
Thermo Scientific Chemicals

2-Methylimidazo-[4,5-c]-pyridin, 99 %, Thermo Scientific Chemicals

CAS: 63604-59-1 | C7H7N3 | 133.154 g/mol
Have Questions?
Ansicht ändernbuttonViewtableView
Menge:
250 mg
1 g
5 g
ChemDexTesten Sie die chem dexTM Webanwendung
Katalognummer L19131.MD
auch als L19131-MD bezeichnet
Preis (EUR)
39,30
Each
Menge:
250 mg
Großbestellung oder individuelle Größe anfordern
Preis (EUR)
39,30
Each
Chemikalien-Kennzeichnungen
CAS63604-59-1
IUPAC Name2-methyl-3H-imidazo[4,5-c]pyridine
Molecular FormulaC7H7N3
InChI KeyJWQVOMJORQXNME-UHFFFAOYSA-N
SMILESCC1=NC2=CC=NC=C2N1
Mehr anzeigen
SpecificationsSpecification SheetDatenblatt
Appearance (Color)White to cream or yellow to pale brown
Assay (Non-aqueous acid-base Titration)≥95.0% to ≤105.0%
FormPowder
Melting Point (clear melt)169-179?C
2-Methylimidazo[4,5-c]pyridine is used as a antagonist against platelet-activating factor (PAF).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Anwendungen
2-Methylimidazo[4,5-c]pyridin wird als Antagonist gegen den Thrombozytenaktivierungsfaktor (PAF) verwendet.

Löslichkeit
Unlöslich in Wasser.

Hinweise
Kühl lagern. Behälter an einem trockenen und gut belüfteten Ort dicht verschlossen halten. Nicht kompatibel mit Oxidationsmitteln.
RUO – Research Use Only

Allgemeine Referenzen:

  1. M. Jonathan Fray, Kelvin Cooper, M. John Parry, Kenneth Richardson, John Steele. Novel Antagonists of Platelet-Activating Factor. 1. Synthesis and Structure-Activity Relationships of Benzodiazepine and Benzazepine Derivatives of 2-Methyl-1-phenylimidazo[4,5-c]pyridine. J. Med. Chem. 1995, 38 (18), 3514-3523.
  2. M. Jonathan Fray, David J. Bull, Kelvin Cooper, M. John Parry, Mark H. Stefaniak. Novel Antagonists of Platelet-Activating Factor. 2. Synthesis and Structure-Activity Relationships of Potent and Long-Acting Heterofused [1,5]Benzodiazepine and [1,4]Diazepine Derivatives of 1-Phenyl-2-methylimidazo[4,5-c]pyridine. J. Med. Chem. 1995, 38 (18), 3524-3535.